(OR=2.30, CI 0.72 to 7.34, p=0.160) and freedom from stroke-related mortality (OR=3.68, CI
Chemexpress (OR=2.30, CI 0.72 to 7.34, p=0.160) and freedom from stroke-related mortality (OR=3.68, CI 0.69 to 19.69, p=0.128). Among the 42 sufferers (22 treated, 20 non-treated) with serious strokes (NIHSS 14)…